AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...
The medicine, which Novo sells as Rybelsus, cut the risk of cardiovascular complications by 14% when added to standard ...
October 10, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription ... GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts ...
One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
Tokyo, Japan and Cambridge, UK, 23 October 2024 - Nxera Pharma Co., Ltd. ("Nxera” or "the Company”; TSE 4565) - formerly ...
Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...
Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...
FRANKFURT: The CEO of pharmaceuticals giant Roche, opens new tab said authorities should block the takeover of contract drug ...
According to a Reuters report, the company has now overtaken Bayer as the largest Germany-headquartered pharma group. For 2024, Boehringer said it expects a “slight” year-on-year increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback